PTK2 and esophageal squamous cell carcinoma: Mechanistically, integrin αV or α6 promoted motility of ESCC cells through different signaling pathways: the former affected FAK-Rac1 signaling pathway [11] while the latter probably deactivated Akt pathway without involving into FAK phosphorylation (Figure 3A).